Search
for
Sort by
Research 121–150 of 160
- Sarcoidosis: Are there differences in your skin of color patients?
- Localized syringolymphoid hyperplasia with alopecia and anhidrosis
- The Role of Sex and Gender in Dermatology - From Pathogenesis to Clinical Implications
- Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network
- Lupus and Pulmonary Nodules Consistent With Bronchiolitis Obliterans Organizing Pneumonia Induced by Carbamazepine
- British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021
- Skin manifestations associated with COVID-19
- Adult Kawasaki's disease with myocarditis, splenomegaly, and highly elevated serum ferritin levels
- Assessment of prescribing information for generic drugs manufactured in the Middle East and marketed in Saudi Arabia
- Skin manifestations associated with systemic diseases – Part I
- Training requirements and recommendation for the specialty of dermatology and venereology <i>European Standards of Postgraduate Medical Specialist Training</i>
- Microscopic polyangiitis secondary to Mycobacterium abscessus in a patient with bronchiectasis: a case report
- Hair diseases: a big problem on a small surface
- Review of systemic methotrexate therapy in pediatric dermatoses
- Prolactin: A Mammalian Stress Hormone and Its Role in Cutaneous Pathophysiology
- Medical Dermatology
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19
- Deficient anterior pituitary with common variable immune deficiency (DAVID syndrome): a new case and literature reports
- 69-Year-Old Man With Nasal Congestion and Pre-Syncope
- Annual Convention in the Time of COVID
- Oral Mesotherapy: Might Be Considered as An Adjunctive Technique for the Different Surgical Procedures?
- Steroid Responsive Mononeuritis Multiplex in the Cronkhite–Canada Syndrome
- 75993 Safety of Janus kinase inhibitors for treatment of alopecia areata
- Pharmacovigilance profiles of three generations of mineralocorticoid receptor antagonists and network toxicology analysis
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data
- Clinicopathological Features and Pathogenesis of Thymoma Complicated with Alopecia Areata: A Multicenter, Matched Case Analysis
- What is causing this patient's worsening rash after topical corticosteroid use?
- Unveiling the immune and vitamin profiles of blood: the potential biomarkers for alopecia areata